While Semler Scientific Inc has overperformed by 5.06%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SMLR rose by 39.76%, with highs and lows ranging from $66.50 to $14.89, whereas the simple moving average fell by -29.76% in the last 200 days.
On July 28, 2025, Cantor Fitzgerald started tracking Semler Scientific Inc (NASDAQ: SMLR) recommending Overweight. A report published by The Benchmark Company on July 08, 2025, Initiated its previous ‘Buy’ rating for SMLR. B. Riley Securities also Downgraded SMLR shares as ‘Neutral’, setting a target price of $45 on the company’s shares in a report dated November 02, 2022.
Analysis of Semler Scientific Inc (SMLR)
Further, the quarter-over-quarter decrease in sales is -44.56%, showing a negative trend in the upcoming months.
In order to gain a clear picture of Semler Scientific Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 17.74% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.95, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 664.32K can be a very valuable indicator of volatility for SMLR stock. On a monthly basis, the volatility of the stock is set at 10.34%, whereas on a weekly basis, it is put at 15.02%, with a gain of 3.34% over the past seven days. Furthermore, long-term investors anticipate a median target price of $51.00, showing growth from the present price of $21.37, which can serve as yet another indication of whether SMLR is worth investing in or should be passed over.
How Do You Analyze Semler Scientific Inc Shares?
The USA based company Semler Scientific Inc (SMLR) is one of the biggest names in Medical Devices. When comparing Semler Scientific Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 7.69, there is a growth in quarterly earnings of 48.89%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 11.84%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 67.33% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
